Immune Checkpoint Drugs May Trigger Nerve Damage in Patients Primed for Neuroinflammation
A large analysis of melanoma patients treated with immune checkpoint inhibitors finds that 12 percent develop significant neurotoxicity, often within ...
A large analysis of melanoma patients treated with immune checkpoint inhibitors finds that 12 percent develop significant neurotoxicity, often within ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine